HIGH
CVE-2023-31075
CWE-352Published: November 18, 2023· Updated: Jun 17, 2026
8.8
CVSS v3.1
Official Description
Cross-Site Request Forgery (CSRF) vulnerability in Arshid Easy Hide Login.This issue affects Easy Hide Login: from n/a through 1.0.8.
Technical Analysis
CVE-2023-31075 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
Exploitation does not require any privileges, though user interaction (Required) is needed, which slightly reduces the risk of mass automated attacks.
A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 8.8.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionRequired
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Affected Vendors & Products
ciphercoin1 product(s)
easy hide login
Source: NVD CPE · 1 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (2)
→
Quick Facts
CVE IDCVE-2023-31075
CVSS Score8.8 / 10
SeverityHIGH
WeaknessCWE-352
CISA KEVNo
Affected1 vendor(s)
PublishedNov 18, 2023
Related CVEs (CWE-352)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2023-31075 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWatch. CVE data is provided under the NVD usage policy.